These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6534118)

  • 1. Cold protected hearts extract oxygen from Fluosol-DA during cardiopulmonary bypass.
    Gartman DM; McDonagh PF; Geha AS
    Adv Exp Med Biol; 1984; 180():443-50. PubMed ID: 6534118
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluosol-DA: an artificial blood for total cardiopulmonary bypass.
    Engelman RM; Rousou JH; Dobbs WA
    Ann Thorac Surg; 1981 Dec; 32(6):528-35. PubMed ID: 7316587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short term survival following perfusion with fluosol-DA for cardiopulmonary bypass.
    Rousou JA; Engelman RM; Breyer RH; Allred C; Forouhar F
    Int J Artif Organs; 1985 Sep; 8(5):281-6. PubMed ID: 3936789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodilution and myocardial oxygen supply. The influence of fluosol-DA.
    Vogel H; Günther H; Harrison DK; Anderer W; Kessler M; Peter K
    Adv Exp Med Biol; 1989; 248():653-61. PubMed ID: 2782181
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of blood and Fluosol-DA for cardiopulmonary bypass.
    Rousou JA; Engelman RM; Anisimowicz L; Dobbs WA
    J Cardiovasc Surg (Torino); 1985; 26(5):447-53. PubMed ID: 4030876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioplegic protection with hypothermic K-Fluosol DA and K/Mg-Fluosol DA solutions.
    Kyösola K; Harjula A; Mattila S; Aalto-Setälä K; Mattila I; Mattila P; Salmenperä M; Merikallio E
    Scand J Thorac Cardiovasc Surg; 1985; 19(3):267-72. PubMed ID: 4081676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local oxygen supply of the myocardium after extreme hemodilution with Fluosol-DA.
    Kessler M; Vogel H; Günther H; Harrison DK; Höper J
    Prog Clin Biol Res; 1983; 122():237-48. PubMed ID: 6878366
    [No Abstract]   [Full Text] [Related]  

  • 8. Oxygen supply and microcirculation of the beating dog heart after haemodilution with fluosol DA 20%.
    Harrison DK; Günther H; Vogel H; Ellermann R; Brunner M; Höper J; Kessler M
    Adv Exp Med Biol; 1985; 191():445-52. PubMed ID: 3832859
    [No Abstract]   [Full Text] [Related]  

  • 9. [Perfluorochemicals (FDA-20%, fluosol), available as cardioplegic solution].
    Nomoto S; Inoue K; Horiuchi M; Yokokawa H; Takaba T; Ishii J
    Kokyu To Junkan; 1985 Nov; 33(11):1355-60. PubMed ID: 4095390
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of the protective effects on the ischemic myocardium of coronary perfusion with perfluorochemicals (fluosol-DA)--a comparison with cold blood cardioplegia].
    Ishimaru S; Hirayama T; Uchino T; Hakoshima A; Hino H; Yamada M; Koike S; Furukawa K; Takahashi M; Yoshihama I
    Nihon Kyobu Geka Gakkai Zasshi; 1986 Jan; 34(1):62-8. PubMed ID: 3711703
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemodynamic, metabolic, and morphological effects of cardiopulmonary bypass with a fluorocarbon priming solution.
    Stone JJ; Piccione W; Berrizbeitia LD; Dance GR; Schoen FJ; Shemin RJ; Cohn LH
    Ann Thorac Surg; 1986 Apr; 41(4):419-24. PubMed ID: 3963919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of the hypertrophied pig myocardium. A comparison of crystalloid, blood, and Fluosol-DA cardioplegia during prolonged aortic clamping.
    Novick RJ; Stefaniszyn HJ; Michel RP; Burdon FD; Salerno TA
    J Thorac Cardiovasc Surg; 1985 Apr; 89(4):547-66. PubMed ID: 3157028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Fluosol-DA during open-heart surgery.
    Engelman RM; Dobbs WA; Rousou JH; Anisimowicz L
    Prog Clin Biol Res; 1983; 122():273-82. PubMed ID: 6878370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of various colloidal solutions during major abdominal surgery.
    Nishimura N; Hiranuma N; Sugi T
    Crit Care Med; 1983 Dec; 11(12):940-2. PubMed ID: 6196154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of controlled reperfusion after ischemia. XIX. Reperfusate composition: benefits of blood cardioplegia over fluosol DA cardioplegia during regional reperfusion--importance of including blood components in the initial reperfusate.
    Acar C; Partington MT; Buckberg GD
    J Thorac Cardiovasc Surg; 1991 Feb; 101(2):284-93. PubMed ID: 1992239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental studies on fluosol DA administration in acute pancreatitis.
    Ohyanagi H; Ohashi O; Nakayama S; Yamamoto M; Okumura S; Saitoh Y
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):585-94. PubMed ID: 3179491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluosol DA-20% in treatment of severe anemia: ongoing studies in 52 patients.
    Spence RK; McCoy S; Costabile J; Norcross ED; Pello M; Alexander J; Atabek U; Wisdom C; Camishion R
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):1069. PubMed ID: 1391428
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of hemodilution with dextran, stroma-free hemoglobin solution and fluosol-DA on experimental myocardial ischemia in the dog.
    Biro GP
    Bibl Haematol; 1981; (47):54-69. PubMed ID: 6175307
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of fluorocarbons with and without oxygen supplementation on cardiac hemodynamics and energetics.
    Rude RE; Bush LR; Tilton GD
    Am J Cardiol; 1984 Oct; 54(7):880-3. PubMed ID: 6207721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red blood cell substitutes and artificial blood.
    Bowman RJ
    Hum Pathol; 1983 Mar; 14(3):218-20. PubMed ID: 6832769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.